Systemic targeted therapy for HER2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline - Mates, M; Fletcher, G G; Freedman, O C (Curr Oncol, 2015)
et al.